Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/1991
02/06/1991EP0411333A1 Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain
02/06/1991EP0411332A1 Antiviral peptides having a 2-oxoalkyl amino acid side chain
02/06/1991EP0411111A1 Ammonium compound, composition containing it and desinfection method.
02/06/1991EP0231209B1 Virus vaccine
02/05/1991US4990646 Preparation of halogenated quinolonecarboxylic acids
02/05/1991US4990530 Indomethacin injections and their production method
02/05/1991US4990517 7-(1-pyrrolidinyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives as antibacterial agents and feed additives
02/05/1991US4990515 Chemical intermediates
02/05/1991US4990510 Substituted indoloquinoxalines
02/05/1991US4990508 Reduced side effects
02/05/1991CA1279868C 3-(substituted)propenylaminothiazolylcephalosporanic acids and esters thereof
02/03/1991CA2022507A1 Process for preparing monobactames and their intermediate product
02/03/1991CA2022382A1 Piperidylthiocarbapenem derivatives
02/01/1991CA2022021A1 Method of resolving cis 3-amino-4-(2-(2-furyl)eth-1-yl)-1-methoxycarbonylmethyl- azetidin-2-one
01/1991
01/31/1991DE3924424A1 Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung Nucleoside derivatives, processes for their preparation, their use as medicaments and to their use in nucleic acid sequencing
01/30/1991WO1991001998A1 Proteins with tnf activity
01/30/1991EP0410762A1 Naphthyridine derivatives
01/30/1991EP0410713A1 Polypeptide inhibitor of viral replication
01/30/1991EP0410660A1 Cyclopentane derivatives
01/30/1991EP0410359A1 Substituted aminoalkoxy-benzene-derivatives
01/30/1991EP0410320A1 Process for preparing lankacidine carbamate derivatives
01/30/1991EP0410148A1 Novel 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and thiones and their use in the prevention or treatment of AIDS
01/30/1991EP0410147A1 Modified VP1/P2A regions of rhinovirus systems
01/30/1991EP0409962A1 Agent for inhibiting symmetrical proteins, in particular enzymes.
01/30/1991EP0409957A1 Biological fluids purification systems
01/30/1991EP0409862A1 Topical preparations.
01/30/1991EP0321548A4 Novel amphiphilic nucleic acid conjugates
01/30/1991CN1048856A Cephalosporin derivatives and processes for their preparation
01/30/1991CN1011410B Quinolonecar boxylic acid derivatives and their preparation
01/30/1991CA2051124A1 Proteins with tnf activity
01/29/1991WO1991001751A1 Biological preparation and its use
01/29/1991WO1991001741A1 Extracts of the acanthospermum hispidum plant
01/29/1991US4988733 N-[1-(3-phenoxyphenyl)ethyl]acetohydroxamic acid compounds which are useful anti-inflammatory agents
01/29/1991US4988709 Quinolone-carboxylic acids as antibacterial agents
01/29/1991US4988686 Cephem compounds and anti-bacterial agent
01/29/1991US4988685 Cephalosporins derivatives
01/29/1991CA2035031A1 Extracts of the acanthospermum hispidum plant
01/29/1991CA2021944A1 Antiherpetic agents
01/29/1991CA1279649C2 Enantioselective process for producing 1-beta-methylcarbapenem antibiotic intermediates
01/29/1991CA1279647C 2-(4-pyridylaminomethyl)-benzimidazole derivatives having antivirus activity
01/29/1991CA1279576C Treatment of skin disorders
01/28/1991WO1991001750A1 Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines
01/28/1991CA2064194A1 Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines
01/28/1991CA2021809A1 Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol) (2r,cis)-1, 2-epoxypropyl-phosphonate with improved characteristics of stability and processing
01/28/1991CA2020888A1 Substituted aminoalkoxybenzene derivatives
01/26/1991WO1991001329A1 Polypeptide inhibitor of viral replication
01/26/1991WO1991001145A1 Pokeweed antiviral protein - monoclonal antibody conjugates
01/26/1991CA2063801A1 Polypeptide inhibitor of viral replication
01/25/1991CA2021784A1 Cyclopentane derivatives
01/24/1991WO1991000869A1 Substitution analogues of magainin peptides
01/24/1991WO1991000865A1 A novel stable form of cephradine, process for its production and intermediates used therein
01/24/1991WO1991000860A1 Nitrogenous ambruticines, process for obtaining them and their use
01/24/1991WO1990014831A3 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
01/23/1991EP0409575A1 Antiviral pyrimidine nucleosides
01/23/1991EP0409242A1 Monoclonal antibody against human CD4 peptide
01/23/1991EP0409227A2 Pyrimidine nucleosides, their preparation and pharmaceutical preparations
01/23/1991EP0409164A2 Phenacylpyridiniothiocephalosporins
01/23/1991EP0409091A1 Antagonists of GM-CSF derived from the carboxyl terminus
01/23/1991EP0409081A1 Beta-Lactam Derivatives
01/23/1991EP0409076A2 Saccharide copolymers having antibacterial activity
01/23/1991EP0409055A1 Cephalosporin derivatives and processes for their preparation
01/23/1991EP0409045A2 Pentapeptide antibiotics derived from dalbaheptides
01/23/1991EP0408973A1 Antiherpes pentapeptides
01/23/1991EP0408727A1 Glycosyl phospholipid nucleoside derivatives and their application as drugs
01/23/1991EP0408674A1 Alternative energy substrate
01/22/1991WO1991001332A1 Feline calicivirus capsid protein and nucleotide sequence
01/22/1991US4987144 1,3-bis(1,2,4-triazol-1-yl)2-(4-trifluoromethylphenyl)propan-2-ol useful for the prevention and/or treatment of deep-seated mycosis
01/22/1991US4987072 Macrocyclic antibiotics
01/22/1991CA1279323C Imidazole derivatives
01/22/1991CA1279277C Treponema hyodysenteriae bacterin and process therefor
01/22/1991CA1279276C Polypeptides and antibiotics characteristic of papillomavirus and use for the in vitro diagnostic, the prevention and/or the control of papillomavirus infections
01/18/1991WO1991001326A1 Antiviral pyrimidine nucleosides
01/18/1991CA2065279A1 Antiviral pyrimidine nucleosides
01/17/1991DE4020211A1 New rhinoviral DNA with mutation(s) in protease 2A region - and corresponding oligo:nucleotide(s) and oligopeptide(s), useful in test systems and as therapeutic competitive inhibitors
01/16/1991EP0408371A1 Hemoregulatory peptides
01/16/1991EP0408336A2 Antitumor antibiotic BU-3285T
01/16/1991EP0408174A1 Antiseptic composition containing hexahydro-5-pyrimidinamine compounds
01/16/1991EP0408017A2 Delivery systems for quaternary and related compounds
01/16/1991EP0407939A1 Antiviral antibiotic BU-3889V
01/16/1991EP0407816A2 Base modified nucleosides
01/16/1991EP0407701A2 Antiretroviral pyrroline and pyrrolidine sulfonic acid derivatives
01/16/1991CN1048496A Aqueous liquid composition for external use
01/16/1991CA2021127A1 Cephalosporin derivatives and processes for their preparation
01/15/1991WO1991001330A1 Antagonists of gm-csf derived from the carboxyl terminus
01/15/1991US4985555 Cephem compounds
01/15/1991US4985549 Process for preparing amikacin
01/15/1991US4985543 Lectins and antiretroviral drugs containing the lectins as active ingredient
01/15/1991US4985451 Elaiophylin derivatives, the use thereof as pharmaceuticals, and pharmaceuticals containing them
01/15/1991US4985243 Endonuclease
01/15/1991US4985063 Insecticides, miticides, herbicides
01/15/1991CA2062975A1 Antagonists of gm-csf derived from the carboxyl terminus
01/15/1991CA2021006A1 Base modified nucleosides
01/13/1991CA2020963A1 Delivery systems for quaternary and related compounds
01/13/1991CA2020891A1 Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and an amphoteric surfactant and methods for preparing same
01/13/1991CA2020740A1 Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines
01/11/1991CA2020800A1 Antiviral antibiotic bu-3889v
01/10/1991WO1991000352A1 Pestivirus nucleotide sequences and polypeptides
01/10/1991WO1991000348A1 Modified vp1/p2a regions of the rhinoviral system
01/10/1991WO1991000282A1 Therapeutic nucleosides
01/10/1991WO1991000093A1 Bis-acyloxymethyl derivatives